Alyeska Investment Group, L.P. - ZS PHARMA INC ownership

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ZS PHARMA INC
ValueSharesWeighting
Q2 2015$5,882,000
-7.7%
112,260
-25.9%
0.03%
-61.4%
Q1 2015$6,375,000
+564.8%
151,507
+556.6%
0.09%
+450.0%
Q4 2014$959,000
+2.1%
23,076
-3.6%
0.02%
-15.8%
Q3 2014$939,000
-70.8%
23,930
-78.6%
0.02%
-73.2%
Q2 2014$3,211,000111,6720.07%
Other shareholders
ZS PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Devon Park Associates, LLC 2,576,723$169,188,00084.73%
DAFNA Capital Management LLC 66,194$4,346,0004.31%
Opaleye Management Inc. 95,000$6,238,0003.07%
Redmile Group, LLC 514,107$33,756,0002.56%
SCOPIA CAPITAL MANAGEMENT LP 1,002,444$65,820,0001.41%
MAZAMA CAPITAL MANAGEMENT INC 76,779$5,041,0001.05%
Kerrisdale Advisers, LLC 45,021$2,956,0000.86%
Rock Springs Capital Management LP 155,000$10,177,0000.83%
USS Investment Management Ltd 590,396$38,765,0000.69%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 21,479$1,410,0000.67%
View complete list of ZS PHARMA INC shareholders